People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

Heavy metal star Ozzy Osbourne reveals the date for his final show, which will also reunite the founding members of Black ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease.

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Sharon Osbourne gave an update on how Parkinson’s disease has impacted husband Ozzy Osbourne’s legs as the musician prepares ...

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

The renowned musician says he plans to keep playing, after confirming the long-suspected diagnosis.

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...